DKSH has established a strategic partnership with Quantum-Si, a leader in Next-Generation Protein Sequencing™, to deliver their solutions in Taiwan. DKSH will leverage its expertise to expand access, empower researchers, and advance scientific discovery in this region.
Taipei, Taiwan, April 2, 2025 – DKSH Business Unit Technology has entered a strategic partnership with Quantum-Si to introduce their Next-Generation Protein Sequencing™ solutions in Taiwan. Through this collaboration, DKSH will provide end-to-end support, including sales and marketing, application engineering, training, and after-sales services, bringing advanced proteomic technologies closer to researchers and laboratories in the region.
Quantum-Si is a leader in biomolecular innovation, pioneering post-genomic research with its cutting-edge Next-Generation Protein Sequencing™ technology. The partnership leverages DKSH’s in-depth market expertise, strong customer network, and comprehensive service capabilities, combined with Quantum-Si’s trailblazing portfolio of proteomics instrumentation, including the “Platinum” products.
Ben Lin, General Manager, Semiconductor, Photovoltaic & Electronics and Industrial Materials & Supplies, Business Unit Technology, DKSH Taiwan, said: “We are delighted to partner with Quantum-Si to expand our market presence and unlock new growth opportunities. With DKSH’s expertise in market research, marketing and sales, and customer service, this partnership will enable us to strengthen Quantum-Si’s reach and raise industry know-how to meet evolving customer needs.”
Jeff Hawkins, Chief Executive Officer, Quantum-Si, stated: “We are excited to collaborate with DKSH to bring Quantum-Si’s Next-Generation Protein Sequencing™ technology to researchers in Taiwan. DKSH’s strong presence and expertise in the region will expand access to the Platinum family of instruments, empowering scientists with cutting-edge protein sequencing capabilities.”
This partnership aims to drive scientific innovation and expand access to next-generation solutions in Taiwan’s life sciences sector. By combining DKSH’s local expertise with Quantum-Si’s technological leadership, both companies are committed to delivering exceptional value and advancing proteomics research.
About Quantum-Si
Quantum-Si pioneers protein research with innovation and precision. Its industry-leading Next-Generation Protein Sequencing™ (NGPS) brings the power of single-molecule proteomics to laboratories worldwide. The Platinum® benchtop sequencer leverages kinetic-based single-amino-acid detection with exceptional sensitivity to protein variants, delivering high-resolution, reliable results that advance protein analysis. www.quantum-si.com/
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec